Table 2

Correlation between MMP-13 expression and clinicopathological parameters of chondrosarcoma patients.

Parameter

No. of patients

MMP-13 immunostaining

P-value


MMP-13 (-ve) (n = 3) %

MMP-13 (+ve) (n = 8) %


Age

>60

6

2 (33.3%)

4(66.7%)

≤ 60

5

1 (20%)

4 (80%)

NS

Sex

Male

7

2 (28.6%)

5(71.4%)

Female

4

1 (25%)

3(75%)

NS

Site

Mandible

8

2 (25%)

6(75%)

Maxilla

3

1 (33.3%)

2(66.7%)

NS

Mitosis

0

3

3 (100%)

0(0%)

1

4

0(0%)

4(100%)

2

2

0(0%)

2(100%)

*S

3

2

0 (0%)

2 (100%)

Necrosis

o

5

3 (60%)

2 (40%)

1

4

0 (0%)

4 (100%)

*S

2

2

0 (0%)

2 (100%)

Grades

G-I

4

3 (75%)

1 (25%)

G-II

5

0 (0%)

5 (100%)

*S

G-III

2

0 (0%)

2 (100%)

Recurrence

+

3

0(0%)

3 (100%)

-

8

3 (37.5%)

5 (62.5%)

NS


P ≤ 0.05 means significant difference

*S = Signficant

NS = Not significant

Necrosis Non = "0", <50% = "1", ≥ 50% = "2".

Mitosis 0–9/10HPF = "1", 10–19/10HPF = "2", ≥ 20/10HPF = "3"

Zyada and Shamaa Diagnostic Pathology 2008 3:26   doi:10.1186/1746-1596-3-26

Open Data